A large meta-analysis study showed that the investigated TLR9 polymorphism rs187084 was significantly associated with an increased risk of overall cancer, particularly cervical cancer, whereas the different polymorphisms rs352140 and rs5743836 in the TLR9 gene exerted a protective role in the development of breast and digestive cancers [39]. The gene discussed is TLR9; the disease is cervical carcinoma.